Epinephrine has been confirmed as the drug of choice for anaphylaxis

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.564, 2008-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to Rituximab: Has the Original Hypothesis Been Confirmed?

Current Pharmaceutical Design, Vol. 21, Iss. 2, 2015-01 ,pp. : 212-220

Bentham Science Publishers

Access to resources Recommend Favorite

Refusal of the marketing authorisation for Sumatriptan Galpharm has been confirmed by the EMA's CHMP.

Reactions Weekly, Vol. 1, Iss. 1380, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Epinephrine: Anaphylaxis: case report

Reactions Weekly, Vol. 1, Iss. 1400, 2012-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Early IM epinephrine advocated for anaphylaxis

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Participation of Maternal and Fetal CRH in Early Phases of Human Implantation: The Role of Antalarmin

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : 75-78

Bentham Science Publishers

Access to resources Recommend Favorite